[1] |
Gao Fan, Wang Ping, Du Chao, Chu Yanliu.
Research progress on intestinal flora and non-surgical treatment of the colorectal cancer
[J]. Journal of International Oncology, 2024, 51(6): 376-381.
|
[2] |
Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.
Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor
[J]. Journal of International Oncology, 2024, 51(5): 298-302.
|
[3] |
Yue Hongyun, Zhang Baihong.
Differentiation therapies in human cancers
[J]. Journal of International Oncology, 2024, 51(2): 109-113.
|
[4] |
Jin Xudong, Chen Zhongjian, Mao Weimin.
Research progress on the role of MTAP in malignant mesothelioma
[J]. Journal of International Oncology, 2024, 51(2): 99-104.
|
[5] |
Cui Tenglu, Lyu lu, Sun Pengfei.
Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma
[J]. Journal of International Oncology, 2023, 50(9): 548-552.
|
[6] |
Chen Xinyi, Weng Yiming, Wei Jiayan, Wang Jinsong, Peng Min.
Advances in immune checkpoint inhibitors in the treatment of recurrent or metastatic head and neck squamous cell carcinoma
[J]. Journal of International Oncology, 2023, 50(9): 553-557.
|
[7] |
Li Chenxi, Zhao Hongwei.
Prognosis and influencing factors of platinum sensitive recurrent ovarian cancer treated by secondary cytoreduction surgery in patients with unsatisfactory primary cytoreduction surgery
[J]. Journal of International Oncology, 2023, 50(6): 342-347.
|
[8] |
Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.
Research progress on the application of combining radiotherapy and systemic therapy in breast cancer
[J]. Journal of International Oncology, 2023, 50(6): 362-367.
|
[9] |
Ju Yifan, Xu Chenyang, Lei Dapeng.
Research progress of pathomics in head and neck neoplasms
[J]. Journal of International Oncology, 2023, 50(5): 294-298.
|
[10] |
Chen Yi, Han Liang, Cai Li.
Multivariate analysis of chemotherapy induced oral mucositis in patients with head and neck tumors
[J]. Journal of International Oncology, 2022, 49(9): 521-525.
|
[11] |
Chu Xuelei, Mao Yun, Xue Peng, Li Linlu, Chen Meichi, Yuan Chunsheng, Qin Xiaoyan, Zhu Shijie.
Effects of chemotherapy dose intensity on short-term efficacy in patients with advanced colon cancer: a study based on real-world data
[J]. Journal of International Oncology, 2022, 49(7): 408-415.
|
[12] |
Tang Lin, Xiang Mingyue, Zhang Jianbo, Wang Lili, Gong Heyi, Han Dali.
Clinical efficacy and safety of camrelizumab combined with apatinib and chemotherapy as second-line or later therapy in the treatment of HER-2 negative advanced gastric cancer
[J]. Journal of International Oncology, 2022, 49(5): 276-281.
|
[13] |
Gao Shile, Lu Donghui, Liu Meiqin, Xu Xingjun, Ma Huan, Zhang Yu.
Clinical efficacy and optimal dose of apatinib combined with chemotherapy in patients with advanced non-small cell lung cancer
[J]. Journal of International Oncology, 2022, 49(3): 140-145.
|
[14] |
Zeng Yan, Luo Pan, Wang Ziqi, Wu Weili.
Mechanism of drug induced ferroptosis in the treatment of head and neck tumors
[J]. Journal of International Oncology, 2022, 49(3): 173-176.
|
[15] |
Lao Zheng, Tu Wenyong, Xu Xuanli, Zhang Lin, Shao Ziyang, Shi Huifeng.
Nimotuzumab combined with definitive radiotherapy for inoperable locally advanced oral and maxillofacial squamous cell carcinoma
[J]. Journal of International Oncology, 2022, 49(11): 665-670.
|